FDA Gives Tentative Approval to New Generic AIDS Drug
Filed in archive Drugs, Vaccines and Therapeutics on May 22, 2006
As part of President Bush's global AIDS relief plan, the US FDA has issued a tentative approval to generic abacavir sulfate tablets, a generic version of GlaxoSmithKline's Ziagen, an anti-HIV medication. Abacavir belongs to a class of drugs called non-nucleoside reverse transcriptase inhibitors (NRTIs), and is used in combination with other antiretroviral agents to inhibit HIV replication.
The drug, manufactured by India-based Aurobindo Pharma Ltd., will now be available for consideration for purchase under the President's Emergency Plan for AIDS Relief.
[Photo: Ziagen tablet, from CORE Center]
Tags: HIV AIDS biotech aids drug aids+drug approval+generic tentative+approval
Vote for FDA Gives Tentative Approval to New Generic AIDS Drug:
|
Rating: 9.00 out of 2 vote(s) cast.
|
Response from:
Trusted.MD Network
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells